HRT Financial’s BioCardia BCDA Stock Holding History

HRT Financial’s Portfolio BCDA Stock Details BCDA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-1,222	Closed	-$12K	–	2326
2023 Q4	$12K	Buy	1,222 +522	+75%	+$4.24K	﹤0.01%	2071
2023 Q3	$4K	Buy	+700	New	+$11.8K	﹤0.01%	2196

Other funds holding BCDA

CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

Family Management New York $834M AUM 20.83% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

HRT Financial's BCDA Position: Q1 2024 in Review

HRT Financial sold out of BioCardia (BCDA) in Q1 2024, closing a stake of 1,222 shares — an estimated $12K sold.

HRT Financial first reported a position in BCDA in Q3 2023 and held it in 2 quarters. The position peaked at $12K in Q4 2023. 22 funds tracked by Wall St. Rank hold BCDA as of Q1 2024.

HRT Financial reported no remaining BioCardia position as of Q1 2024 after selling out during the quarter.
HRT Financial sold 1,222 BioCardia shares in Q1 2024, an estimated $12K.
HRT Financial first reported a position in BioCardia in Q3 2023 and held it in 2 quarters.
HRT Financial's BioCardia position peaked at $12K in Q4 2023.
22 funds tracked by Wall St. Rank held BioCardia as of Q1 2024.

Based on HRT Financial's 13F filing for Q1 2024, filed 13 May 2024.